Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Asahi Kasei Pharma Contracts ProBioGen | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

Asahi Kasei Pharma Contracts ProBioGen

Will use ProBioGen’s technologies for the advancement of its biologics pipeline.

By: Contract Pharma

Contract Pharma Staff

ProBioGen AG has closed a master service agreement with Asahi Kasei Pharma. As a CDMO in high-tier cell line development till large scale GMP manufacturing, ProBioGen will use its proprietary technologies, like the CHO.RiGHT cell line development platform and DirectedLuck transposase technology, to enable Asahi Kasei Pharma to advance their biologics pipeline.
 
“We are enchanted to work with Asahi Kasei Pharma on one of their key projects and are convinced that we can make a difference by applying our inventive technologies,” said Dr. Gabriele Schneider, chief business officer at ProBioGen.
 
Osamu Matsuzaki, senior executive officer at Asahi Kasei Pharma added, “After an intense selection process we decided to work with a very experienced and reliable partner as this is critical for the success of our project. We are impressed with ProBioGen’s track record and their deep scientific insights, which led to a tailored development project.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics